Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.82 - $3.24 $85 - $152
-47 Reduced 52.22%
43 $0
Q4 2021

Feb 08, 2022

BUY
$2.36 - $4.05 $37 - $64
16 Added 21.62%
90 $0
Q3 2021

Nov 15, 2021

SELL
$3.75 - $4.86 $2,497 - $3,236
-666 Reduced 90.0%
74 $0
Q2 2021

Sep 13, 2021

BUY
$3.83 - $5.65 $2,834 - $4,181
740 New
740 $4,000

Others Institutions Holding BLPH

# of Institutions
1
Shares Held
44K
Call Options Held
0
Put Options Held
0

About Bellerophon Therapeutics, Inc.


  • Ticker BLPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,545,450
  • Market Cap $95.5K
  • Description
  • Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...
More about BLPH
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.